Over the past several years continued clinical trials and studies on PQQ show it to have positive effects on some of the difficult chronic disorders. There has been a lot of coverage about Alzheimer’s and Parkinson’s diseases.
The collective studies about these chronic debilitating disorders now show that PQQ is also a very promising therapeutic agent for those who are suffering from diabetes, rheumatoid arthritis and osteoarthritis. It’s another tool to help give some relief and in some specific testimonials, go even further.
As the link between arthritis and mitochondria deficiencies becomes more and more evident the last couple of years, it’s not hard to imagine why scientists and researchers looked into PQQ as a way to help stop the disease. After all, PQQ has been shown to help rebuild damaged mitochondria and add new healthy mitochondria.
In a recent study in the last few years, the benefits of PQQ on degenerative joint diseases in animals were documented. Animals treated with PQQ supplementation showed an improvement in their joint health and their arthritis was reduced. The researchers concluded in this study that PQQ was expected to have a novel application in the prevention and treatment of osteoarthritis in the not so distant future.
In addition to being an extreme antioxidant, scientists have found that PQQ exerts potent immunosuppressive effects in circumstances where autoimmune inflammation is acute.
Another clinicial study was done on mice that had diabetes. They were tested for how much oxidative stress & inflammation they had compared to mice that did not have diabetes. The researchers measured the amount of insulin, cholesterol, glucose, uric acide and triglycerades along with the functions of the kidneys, pancreas and livers. These animals were found to have very high levels of free radicals and oxidative stress; however when treated with PQQ, the animals cholesterol and blood sugar levels got better.
After just 15 days of high doses of PQQ, the animal’s diabetes regressed.
A double-blinded, random, placebo-controlled human study was done in Japan on healthy adults who had elevated LDL cholesterol and moderately high triglycerides. Slight yet significant decreases in LDL markers were recorded with the individuals who took PQQ vs the placebo.
The results in animal study and now new human clinical trials shows great promise that PQQ can be used to treat a wide range of chronic debilitating disorders.